3-(p-Fluorobenzoyloxy)tropane

Source: Wikipedia, the free encyclopedia.
3-(p-Fluorobenzoyloxy)tropane
Clinical data
Routes of
administration		insufflated
Legal status
Legal status
  • DE: Anlage II (Authorized trade only, not prescriptible)
Identifiers
  • (1R,5S)-(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 4-fluorobenzoate
JSmol)
  • CN1C2CC(OC(C3=CC=C(F)C=C3)=O)CC1CC2
  • InChI=1S/C15H18FNO2/c1-17-12-6-7-13(17)9-14(8-12)19-15(18)10-2-4-11(16)5-3-10/h2-5,12-14H,6-9H2,1H3 checkY
  • Key:YXDFSLSXLYAAPF-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

3β-(p-Fluorobenzoyloxy)tropane, (8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 4-fluorobenzoic acid ester, 4-fluorotropacocaine, 3-Pseudotropyl-4-fluorobenzoate, 3-pseudotropyl-4-fluorobenzoate, pFBT) is a

EMCDDA in 2008,[2][3] and subsequently sold as an ingredient of various "bath salt" powder products, usually mixed in combination with other stimulant drugs such as caffeine, dimethocaine, desoxypipradrol or substituted cathinone derivatives.[4]

See also

References

  1. ISBN 0-306-44035-0
  2. PMID 21083227
    .
  3. PMID 22102564
    .
  4. PMID 22102551
    .
Retrieved from "https://en.wikipedia.org/w/index.php?title=3-(p-Fluorobenzoyloxy)tropane&oldid=1209715403"